Showing results (451-460 of 1,015) with videos related to

Sort By:
Pageof 102
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2006
Pregabalin (Lyrica) in the treatment of essential tremorTheresa A Zesiewicz, Christopher L Ward, Robert A Hauser, et al.
Transplantation Reviews (Orlando, Fla.)|March 12, 2016
Immunological risk assessment: The key to individualized immunosuppression after kidney transplantationJohann Pratschke, Duska Dragun, Ingeborg A Hauser, et al.
Alzheimer'S Research & Therapy|December 6, 2014
Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromesNin Bajaj, Robert A Hauser, John Seibyl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's diseaseRobert A Hauser, William C Koller, Jean P Hubble, et al.
Epilepsia|May 1, 1994
EEG abnormalities in children with a first unprovoked seizureS Shinnar, H Kang, A T Berg, et al.
The Lancet. Neurology|August 2, 2016
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targetsAlberto J Espay, Peter A LeWitt, Robert A Hauser, et al.
Annals of Human Genetics|May 6, 2006
Myotilin is not the causative gene for vocal cord and pharyngeal weakness with distal myopathy (VCPDM)Sean M Garvey, Jan Senderek, Jacques S Beckmann, et al.
Clinical Neuropharmacology|November 11, 2006
Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson diseaseRobert A Hauser, Hermann Russ, Doris-Anita Haeger, et al.
Clinical Neuropharmacology|May 28, 2009
Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson diseaseTheresa A Zesiewicz, Robert A Hauser, Alan Freeman, et al.
Neurology|January 6, 2011
Estimating risk for developing epilepsy: a population-based study in Rochester, MinnesotaD C Hesdorffer, G Logroscino, E K T Benn, et al.
Pageof 102